Bogdan Nowakowski, MD
Pulmonary Disease · Gonzales, LANPI 1659476265
Payments from drug & device makers
Across 502 payments — averaging $22.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- GSK$1K
- AbbVie$967
- Redhill Biopharma Inc.$899
- AstraZeneca$858
- Takeda Pharmaceuticals U.S.A., Inc.$757
- plus $5K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 83 | $1,742 |
| GSK | 33 | $1,067 |
| AbbVie(2 entities) | 46 | $967 |
| Redhill Biopharma Inc. | 43 | $899 |
| AstraZeneca | 25 | $858 |
| Takeda Pharmaceuticals U.S.A., Inc. | 38 | $757 |
| Ironwood Pharmaceuticals, Inc | 39 | $670 |
| Ardelyx, Inc. | 19 | $494 |
| Boehringer Ingelheim | 14 | $408 |
| Johnson & Johnson | 23 | $365 |
| Gilead | 4 | $349 |
| Ipsen Biopharmaceuticals, Inc | 15 | $341 |
| Merck | 20 | $292 |
| Phathom Pharmaceuticals, Inc. | 17 | $283 |
| QOL Medical, LLC | 14 | $278 |
| Madrigal Pharmaceuticals | 9 | $220 |
| Braintree Laboratories, Inc. | 10 | $197 |
| Intercept Pharmaceuticals, Inc. | 5 | $196 |
| Sanofi | 3 | $174 |
| Regeneron Healthcare Solutions, Inc. | 3 | $149 |
| Paratek Pharmaceuticals, Inc. | 7 | $130 |
| Shionogi Inc | 7 | $128 |
| Pulmonx Corporation | 1 | $92 |
| Insmed, Inc. | 4 | $80 |
| Genentech USA, Inc. | 1 | $72 |
| Viatris Specialty LLC | 4 | $70 |
| Mylan Specialty L.p. | 3 | $66 |
| Romark Laboratories, LC | 3 | $44 |
| Baxter Healthcare | 2 | $39 |
| Circassia Inc. | 2 | $23 |
| Lilly USA, LLC | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Valinor Pharma, LLC | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| CSL Behring | 1 | $15 |
How this compares
$11,537 in reported general payments places this provider in the 70th percentile of 189 pulmonary disease providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Gonzales
- Gretchen YandleGonzales$11K
- David GreenShreveport$2M
- Joseph LaskyNew Orleans$1.9M
- Leonardo SeoaneNew Orleans$1.6M
- Ross KlingsbergNew Orleans$1.2M
- Juzar AliNew Orleans$775K
- Hollis O NealBaton Rouge$682K
- Andrea EspinozaHouma$655K
- Ramsy AbdelghaniNew Orleans$474K
- Bennett DeboisblancNew Orleans$457K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.